All News

Nipple- and skin-sparing mastectomy is now an option for women, but it comes with choices and may not be for everyone.

For patients with stage 3 colorectal cancer and normal KRAS gene activity, Erbitux (cetuximab) did not extend survival when added to chemotherapy.

In two separate early-stage breast cancer studies, researchers examined the benefit of testing for traveling cancer cells that may have broken off the tumor site and additional surgery if those roaming cells were found.

Three drugs, which use different mechanisms to target cancer, highlighted at annual oncology meeting.

Researchers have developed a new screening approach that produces very few false positives in postmenopausal women with an average risk of ovarian cancer.

Finalist essay written by Greg Frazee nominating nurse Annette Graham, NP, AOCNP, from the Virginia Cancer Institute, for CURE's 2010 Extraordinary Healer Award contest.

Separate studies show that maintenance therapy, treatment given after initial therapy to prolong remission, can benefit patients with certain blood cancers.

A new chemotherapy drug, called eribulin, extended survival by two and a half months in patients with locally recurrent or metastatic breast cancer whose cancers continued to progress despite treatment with numerous other drugs.